Viewing StudyNCT00262067



Ignite Creation Date: 2024-05-05 @ 4:35 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00262067
Status: UNKNOWN
Last Update Posted: 2013-12-13
First Post: 2005-12-02

Brief Title: A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer RIBBON 1
Sponsor: Genentech Inc
Organization: Genentech Inc

Organization Data

Organization: Genentech Inc
Class: INDUSTRY
Study ID: AVF3694g
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Genentech Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators